GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,400.00
+100.00 (1.59%)
At close: Jun 10, 2026

GFC Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '21 Dec '20 Dec '19
33,68874,59763,836---
Market Cap Growth
-55.77%16.86%----
Enterprise Value
36,19472,09770,233---
Last Close Price
6400.0014200.0014500.00---
PE Ratio
43.98134.31----
PS Ratio
1.844.213.80---
PB Ratio
1.373.145.86---
P/TBV Ratio
1.513.396.12---
P/OCF Ratio
31.2154.5721.52---
EV/Sales Ratio
1.984.074.18---
EV/EBITDA Ratio
16.1734.3021.36---
EV/EBIT Ratio
79.97186.6541.20---
Debt / Equity Ratio
0.340.320.640.901.510.85
Debt / EBITDA Ratio
3.763.582.143.2513.64233.28
Debt / FCF Ratio
---20.79--
Net Debt / Equity Ratio
0.10-0.010.500.761.410.70
Net Debt / EBITDA Ratio
1.12-0.121.672.7212.80191.73
Net Debt / FCF Ratio
-0.300.04-153.0517.41-5.00-1.73
Asset Turnover
-0.66-0.710.650.60
Inventory Turnover
-16.83-11.1812.8411.69
Quick Ratio
4.054.920.480.420.241.46
Current Ratio
4.785.600.570.530.341.72
Return on Equity (ROE)
4.13%3.20%-21.78%-28.76%4.26%
Return on Assets (ROA)
-0.90%-4.42%-0.02%-2.37%
Return on Invested Capital (ROIC)
1.79%1.93%11.06%8.82%-0.04%-4.28%
Return on Capital Employed (ROCE)
1.30%1.20%12.90%12.50%-0.10%-4.30%
Earnings Yield
2.18%0.74%-9.32%---
FCF Yield
-24.41%-8.51%-0.06%---
Buyback Yield / Dilution
-43.92%-51.63%-206.48%-0.01%-0.02%-100.00%